Emad M El-Omar
Overview
Explore the profile of Emad M El-Omar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
7129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tseng C, Wong S, Yu J, Lee Y, Terauchi J, Lai H, et al.
Gut
. 2025 Feb;
PMID: 40011030
Objective: Live biotherapeutic products (LBPs) are biological products composed of living micro-organisms, developed to prevent, treat, or cure diseases. Examples include cultured strains of and , as well as treatments...
2.
3.
Hicks C, Leonardi M, Chua X, Mari-Breedt L, Espada M, El-Omar E, et al.
BJOG
. 2024 Oct;
132(3):326-336.
PMID: 39431364
Objective: To identify a microbial signature for endometriosis for use as a diagnostic non-invasive biomarker. Design: Prospective cohort pilot study. Setting: Nepean Hospital and UNSW Microbiome Research Centre, Australia. Population:...
4.
Van Hul M, Cani P, Petitfils C, de Vos W, Tilg H, El-Omar E
Gut
. 2024 Sep;
73(11):1893-1908.
PMID: 39322314
The understanding that changes in microbiome composition can influence chronic human diseases and the efficiency of therapies has driven efforts to develop microbiota-centred therapies such as first and next generation...
5.
Dinis-Ribeiro M, Shah S, El-Serag H, Banks M, Uedo N, Tajiri H, et al.
Gut
. 2024 Aug;
73(10):1607-1617.
PMID: 39122364
Objective: During the last decade, the management of gastric intestinal metaplasia (GIM) has been addressed by several distinct international evidence-based guidelines. In this review, we aimed to synthesise these guidelines...
6.
Feng Y, Zheng H, Yin C, Liang D, Zhang S, Chen J, et al.
Cell Rep Med
. 2024 Aug;
5(8):101678.
PMID: 39096912
Chemotherapy-induced premature ovarian insufficiency (CIPOI) triggers gonadotoxicity in women undergoing cancer treatment, leading to loss of ovarian reserves and subfertility, with no effective therapies available. In our study, fecal microbiota...
7.
Liou J, Malfertheiner P, Smith S, El-Omar E, Wu M
Lancet
. 2024 Jun;
403(10444):2570-2572.
PMID: 38879242
No abstract available.
8.
Rugge M, Genta R, Malfertheiner P, Dinis-Ribeiro M, El-Serag H, Graham D, et al.
Gut
. 2024 Feb;
73(3):407-441.
PMID: 38383142
At the end of the last century, a far-sighted 'working party' held in Sydney, Australia addressed the clinicopathological issues related to gastric inflammatory diseases. A few years later, an international...
9.
Chen Y, Malfertheiner P, Yu H, Kuo C, Chang Y, Meng F, et al.
Gastroenterology
. 2024 Jan;
166(4):605-619.
PMID: 38176660
Background & Aims: We aimed to assess the secular trend of the global prevalence of Helicobacter pylori (H pylori) infection in adults and children/adolescents and to show its relation to...
10.
Zhang N, Zhu W, Zhang S, Liu T, Gong L, Wang Z, et al.
Microb Ecol
. 2023 Nov;
87(1):5.
PMID: 38030815
Cholangiocarcinoma (CCA) is a serious health problem worldwide. The gut and bile microbiota have not been clearly characterized in patients with CCA, and better noninvasive diagnostic approaches for CCA need...